![uploads///Chart NewProducts](https://media.marketrealist.com/brand-img/wQusO4rAl/640x335/uploads/2017/07/Chart-03-NewProducts-1.jpg 640w)
Eli Lilly in 2Q17: Performance of New Products
For 2Q17, Basaglar sales were $86.6 million. Of that, $60.0 million was from sales in the US markets, while $27.0 million was from international sales.
The latest news in the healthcare sector including biotech and telehealth.